AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 2 393-R397, Copyright © 1996 by American Physiological Society

ARTICLES

Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ

H. Suzuki, X. P. Gao, C. O. Olopade and I. Rubinstein
Department of Medicine, University of Illinois at Chicago 60612-7323, USA.

The purpose of this study was to determine whether vasoactive intestinal peptide (VIP) dilates resistance arterioles in the in situ systemic circulation and whether inhibitors of neutral endopeptidase (NEP) and angiotensin I-converting enzyme (ACE), two membrane-bound metalloenzymes that are widely distributed in the microcirculation and cleave and inactive VIP, potentiate this response. Using intravital microscopy, we found that VIP (0.05 and 0.1 nmol) induced significant vasodilation in the hamster cheek pouch (13 +/- 1 and 20 +/- 2% increase from baseline, respectively; mean +/- SE; P < 0.05). These responses were significantly potentiated by topical application of phosphoramidon and thiorphan, two relatively selective NEP inhibitors, but not by captopril, a relatively selective ACE inhibitor. Furthermore, suffusion of a mixture of proteinase inhibitors consisting of leupeptin, Bestatin, and DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid to inhibit serine proteinases, including mast cell tryptase, aminopeptidases, and carboxypeptidase N, respectively, had no significant effects on VIP-induced responses. These data indicate that VIP elicits vasodilation in the in situ systemic microcirculation and that NEP modulates this response.

This article has been cited by other articles:

				T. Tsueshita, S. Gandhi, H. Onyuksel, and I. Rubinstein Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(138) J Appl Physiol, October 1, 2002; 93(4): 1377 - 1383. [Abstract] [Full Text] [PDF]

				I. Rubinstein, R. Chandilawa, S. Dagar, D. Hong, and X.-P. Gao Adenosine A1 receptors mediate plasma exudation from the oral mucosa J Appl Physiol, August 1, 2001; 91(2): 552 - 560. [Abstract] [Full Text] [PDF]

				I. Rubinstein, J. Potempa, J. Travis, and X.-P. Gao Mechanisms Mediating Porphyromonas gingivalis Gingipain RgpA-Induced Oral Mucosa Inflammation In Vivo Infect. Immun., February 1, 2001; 69(2): 1199 - 1201. [Abstract] [Full Text] [PDF]

				H. Suzuki, H. Ikezaki, D. Hong, and I. Rubinstein PGH2-TxA2-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension J Appl Physiol, June 1, 2000; 88(6): 1983 - 1988. [Abstract] [Full Text] [PDF]

				I. Rubinstein Smokeless tobacco potentiates VIP-induced DNA synthesis and inactivates NEP 24.11 in oral keratinocytes Am J Physiol Cell Physiol, February 1, 2000; 278(2): C391 - C396. [Abstract] [Full Text] [PDF]

				S. R. Akhter, H. Ikezaki, X.-P. Gao, and I. Rubinstein Dexamethasone attenuates grain sorghum dust extract-induced increase in macromolecular efflux in vivo J Appl Physiol, May 1, 1999; 86(5): 1603 - 1609. [Abstract] [Full Text] [PDF]

				H. Ikezaki, M. Patel, H. Onyuksel, S. R. Akhter, X.-P. Gao, and I. Rubinstein Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1359 - R1365. [Abstract] [Full Text] [PDF]

				H. Ikezaki, H. Onyuksel, and I. Rubinstein Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R588 - R595. [Abstract] [Full Text] [PDF]

				H. Ikezaki, S. Paul, H. Alkan-Onyuksel, M. Patel, X.-P. Gao, and I. Rubinstein Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R56 - R62. [Abstract] [Full Text] [PDF]